NCT04353128View on ClinicalTrials.gov

Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

April 20, 2020

Primary Completion Date

October 1, 2020

Study Completion Date

December 1, 2020

Conditions
Covid19SARS-CoV 2Coronavirus Infection
Interventions
DRUG

Melatonin 2mg

2 mg of prolonged release melatonin tablets per os (P.O.) before bedtime for 12 weeks

DRUG

Placebo oral tablet

Identically looking placebo tablets P.O. before bedtime for 12 weeks

Trial Locations (1)

28046

Hospital Universitario La Paz, Madrid

All Listed Sponsors
lead

Instituto de Investigación Hospital Universitario La Paz

OTHER

NCT04353128 - Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers. | Biotech Hunter | Biotech Hunter